NOV
49
-6
STT
59
14
MKC
53
2
SYF
71
-3
CCL
51
3
AIV
44
-3
MLM
32
5
WM
54
4
ADI
62
5
MU
52
-6
STI
10
-13
PBI
35
2
NOC
45
2
MHK
33
3
IRM
25
4
VRTX
49
3
NAVI
35
-5
ABT
57
3
FTI
81
3
NI
65
9
NOV
49
-6
STT
59
14
MKC
53
2
SYF
71
-3
CCL
51
3
AIV
44
-3
MLM
32
5
WM
54
4
ADI
62
5
MU
52
-6
STI
10
-13
PBI
35
2
NOC
45
2
MHK
33
3
IRM
25
4
VRTX
49
3
NAVI
35
-5
ABT
57
3
FTI
81
3
NI
65
9
Financhill
Back

Invesco ESG NASDAQ 100 Index ETF CAD Hedged Units Vs. Janux Therapeutics Industry Stock Comparison

Sell
35

QQCE.F.TO
Invesco ESG NASDAQ 100 Index ETF CAD Hedged Units

Last Price:
$25.80
Seasonality Move:
3.75%
Sell
23

JANX
Janux Therapeutics

Last Price:
$50.53
Seasonality Move:
80.32%
Sell
35
Invesco ESG NASDAQ 100 Index ETF CAD Hedged Units (QQCE.F.TO) is a Sell

Is Invesco ESG NASDAQ 100 Index ETF CAD Hedged Units a Buy, Sell or Hold?

  • The current Invesco ESG NASDAQ 100 Index ETF CAD Hedged Units [QQCE.F.TO] share price is $25.80. The Score for QQCE.F.TO is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • QQCE.F.TO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy, Sell or Hold?

  • The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

QQCE.F.TO Stock Price Chart

What is Invesco ESG NASDAQ 100 Index ETF CAD Hedged Units's stock price today?

JANX Stock Price Chart

What is Janux Therapeutics's stock price today?

  • The Janux Therapeutics share price today is $50.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

QQCE.F.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.2 Buy
Relative Strength Index (14 RSI): 47.7 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.15 - 26.23) Buy
Bollinger Bands (100): (23.59 - 25.57) Buy

JANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 41.88 Sell
Chaikin Money Flow: -1994706 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.74 - 62.68) Sell
Bollinger Bands (100): (44.76 - 56.7) Buy

QQCE.F.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 26.13 Sell
20-day SMA: 25.82 Sell
50-day SMA: 25.34 Buy
200-day SMA: 23.75 Buy
8-day EMA: 25.93 Sell
20-day EMA: 25.81 Sell
50-day EMA: 25.37 Buy
200-day EMA: 23.71 Buy

JANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.68 Sell
20-day SMA: 56.78 Sell
50-day SMA: 54.64 Sell
200-day SMA: 47.7 Buy
8-day EMA: 54.12 Sell
20-day EMA: 55.17 Sell
50-day EMA: 54.12 Sell
200-day EMA: 45.19 Buy

Invesco ESG NASDAQ 100 Index ETF CAD Hedged Units Earnings Growth & QQCE.F.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Janux Therapeutics Earnings Growth & JANX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.

Invesco ESG NASDAQ 100 Index ETF CAD Hedged Units Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Janux Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):